Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SJ000291942
Cat. No.:
OB0225LY-0197
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
SJ000291942 is a small molecule compound with the ability to inhibit specific cell signaling pathways.
Synonym:
425613-09-8; 2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide
CAS No.:
425613-09-8
Compound CID:
875819
Formula:
C16H15FN2O4
Formula Weight:
318.3
Specification
Relative Density:
1.327 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SJ000291942 can be used in cell biology research or play an important role in exploring applications in mechanistic diseases.
Library Information
Targets:
TGF-β receptor family
Pathways:
Stem cells; TGF-beta/Smad signaling
Plate Number:
AOCL-3
Plate Location:
d11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 188.5 mM
